DCF — LAFAYETTE GENERAL MEDICAL CENTER
Enterprise Value: $-1.2B
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-1.2B
Enterprise Value
$-368.5M
PV of Cash Flows
$-823.0M
PV of Terminal Value
$-1.3B
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $494.6M | $-78.8M | -16.0% | $-99.8M | $-90.7M |
| Year 2 | $509.4M | $-76.1M | -15.0% | $-97.7M | $-80.7M |
| Year 3 | $524.7M | $-73.1M | -14.0% | $-95.4M | $-71.6M |
| Year 4 | $540.5M | $-72.6M | -13.0% | $-95.5M | $-65.2M |
| Year 5 | $556.7M | $-73.4M | -13.0% | $-97.0M | $-60.2M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-1.2B. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$480.2M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.1644035679144897
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5